Which of the following NSAIDs has been approved for use in children?
**Core Concept:** Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of medications used to alleviate pain, inflammation, and fever. They target the enzyme cyclooxygenase (COX), which plays a role in prostaglandin synthesis. There are two main isoforms: COX-1 and COX-2. COX-1 maintains gastrointestinal integrity, while COX-2 is involved in inflammation.
**Why the Correct Answer is Right:** Salicylic acid (acetylsalicylic acid) is the active ingredient in aspirin (salicylic acid + salicylic acid) and is a selective COX-1 inhibitor. Aspirin is contraindicated in children due to the risk of Reye's syndrome, a rare but severe condition characterized by liver and brain dysfunction. Therefore, aspirin is not approved for pediatric use.
**Why Each Wrong Option is Incorrect:**
A. Ibuprofen (C13H22O3): This is a nonselective NSAID that inhibits both COX-1 and COX-2 enzymes. Although it has a lower risk of Reye's syndrome compared to aspirin, it is still contraindicated in children due to potential gastrointestinal and renal complications.
B. Naproxen (C15H14O3): A nonselective NSAID that inhibits both COX-1 and COX-2 enzymes, similar to ibuprofen. Contraindicated in children due to potential complications.
C. Salicylic acid: The active ingredient in aspirin, which is contraindicated in children as explained above.
D. Salicylic acid + salicylic acid (salicylic acid dimer): A less potent inhibitor of COX enzymes compared to aspirin monomer. It is still contraindicated in children due to the risk of Reye's syndrome.
**Clinical Pearl:** Children's bodies are more susceptible to Reye's syndrome due to their immature liver and gut microbiome. In adults, the risk is lower but still exists, especially in those with gastrointestinal or renal disease.
**Correct Answer:** D. Salicylic acid + salicylic acid (salicylic acid dimer): This option represents the dimerized form of salicylic acid, which is the active ingredient in aspirin. Although it is less potent than aspirin monomer, it still poses a risk of Reye's syndrome in children, making it contraindicated in this age group.
**Why This is a Clinical Pearls Exam Question:** This question tests the understanding of contraindications and potential complications of commonly used medications in pediatric patients, which is crucial for safe patient care and informed decision-making in clinical practice. It highlights the risks associated with Reye's syndrome in children and the need for caution when prescribing medications, particularly NSAIDs, to this population.